Form 4 for NVCR NovoCure Ltd
Accepted 2026-06-05 16:26:06 ET · period of report 2026-06-03 · accession 0001696864-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-05 16:26 | 2026-06-03 | NVCR | Madden Martin J. | Dir | A - Grant | $0.00 | +11.6K | 30.3K | +62% | $0 |
| D | 2026-06-05 16:26 | 2026-06-03 | NVCR | Madden Martin J. | Dir | A - Grant | $0.00 | +17.0K | 17.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-03 | A | A | 11,610 | $0.00 | 30,284 | D | — | — | (F1) Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-03 | A | A | 16,999 | $0.00 | 16,999 | D | $16.15 · 2027-06-03 to 2036-06-03 | 16,999 Ordinary Shares | (F2) Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders. |